...
机译:基于吡咯并3,2-d嘧啶的EGFR T790M/L858R突变抑制剂发现结构方法
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan;
EGFR T790/L858 mutant inhibitors; NSCLC; drug sensitivity and resistance; crystal structure; pyrrolo3; 2-dpyrimidine derivatives; TAK-285;
机译:Discovery of selective EGFR modulator to inhibit L858R/T790M double mutants bearing a N-9-Diphenyl-9H-purin-2-amine scaffold
机译:Discovery of 5-(methylthio)pyrimidine derivatives as L858R/T790M mutant selective epidermal growth factor receptor (EGFR) inhibitors
机译:Discovery of new 1,4dioxino2,3-fquinazoline-based inhibitors of EGFR including the T790M/L858R mutant
机译:基于AI的TKI靶向L858R / T790M / C797S-MUTANT EGFR在非小细胞肺癌中的药物发现
机译:基于结构的Pyrolo 3,2-D嘧啶的EGFR T790M / L858R突变体抑制剂的方法